RxDoctor Payments Data
★ My doctorsLook up a doctor →

Muhammad Raza, MD

Interventional Cardiology · Browns Mills, NJNPI 1629308150

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (52.6%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. 33 manufacturers reported payments, led by Johnson & Johnson at 56.3% of the total. Reporting peaked in 2022 at $23,243 and has fallen 83.5% since, to $3,835 in 2025. Among interventional cardiology clinicians in NJ with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$60,437in general payments, 2019–2025

Across 340 payments — averaging $177.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$34K
  • Janssen Scientific Affairs, LLC$9K
  • Edwards Lifesciences$4K
  • Medtronic$3K
  • Abbott$3K
  • Ancora Heart, Inc.$2K
  • plus $5K from 27 others

What the payments were for

  • Consulting fees$8,00013%
  • Speaking & faculty fees$31,78553%
  • Travel & lodging$6,40411%
  • Food & beverage$14,19323%
  • Education$540%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Johnson & Johnson52$34,028
Janssen Scientific Affairs, LLC9$8,933
Edwards Lifesciences20$3,756
Medtronic(2 entities)40$2,969
Abbott35$2,933
Ancora Heart, Inc.12$2,347
Boston Scientific44$1,608
Abiomed18$604
Penumbra, Inc.6$557
Biotronik Inc.7$451
Amgen15$421
Pfizer25$338
W. L. Gore & Associates, Inc.2$193
Cardiac Dimensions, Inc.2$147
E.r. Squibb & Sons, L.L.C.8$139
AstraZeneca7$117
Chiesi USA, Inc.7$116
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)4$100
Philips North America LLC1$99
Siemens Medical Solutions USA, Inc.1$94
Kestra Medical Technology Services, Inc.1$77
Sanofi-aventis U.S. LLC4$73
GSK3$62
Amarin Pharma, Inc.4$61
Regeneron Healthcare Solutions, Inc.4$48
Angiodynamics, Inc.2$35
Teleflex LLC1$32
Endologix LLC1$22
Novartis1$19
Cardiva Medical, Inc.1$17
Terumo Medical Corporation1$15
Biosense Webster, Inc.1$14
Acarix USA Inc.1$11

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$60,437 in reported general payments places this provider in the 90th percentile of 166 interventional cardiology providers in New Jersey.

See all interventional cardiology providers in New Jersey →

Medicare billing

Part B allowed, 2024
$168,052
Medicare patients
253
Services billed
637

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Warfarin Sodium16$56

Paid to pharmacies, not to this prescriber.

Other interventional cardiology in Browns Mills

See the full list for New Jersey →

Where these figures come from

Is this you, or does something look wrong? →